Company Filing History:
1 out of 15 
1 out of 12 
Years Active: 2025
Title: Gareth Hall: Innovator in Alzheimer's Disease Treatment
Introduction
Gareth Hall is a notable inventor based in Leicester, GB. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. His innovative work has led to the development of a unique patent that addresses critical challenges in this area.
Latest Patents
Gareth Hall holds a patent for a "Humanised anti-n-truncated amyloid β monoclonal antibody." This invention relates to humanised antibodies that bind amyloid peptides. The antibodies comprise mutations in the heavy chain and/or light chain variable domains, which mutations improve the binding activity. These antibodies may be useful in the treatment of Alzheimer's disease (AD). He has 1 patent to his name.
Career Highlights
Throughout his career, Gareth has worked with several esteemed institutions. He has been associated with Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin, and LifeArc. His work in these organizations has contributed to advancements in medical research and innovation.
Collaborations
Gareth has collaborated with notable professionals in his field, including Thomas Bayer and Preeti Bakrania. These collaborations have further enhanced his research and development efforts.
Conclusion
Gareth Hall's contributions to the field of Alzheimer's disease treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in this critical area.